• Profile
Close

Urolithin A inhibits epithelial-mesenchymal transition in lung cancer cells via P53-Mdm2-Snail pathway

OncoTargets and Therapy May 28, 2021

Cheng F, Dou J, Zhang Y, et al. - Researchers investigated how urolithin A, a major metabolite from pomegranate ellagitannins, could impact Snail (a zinc finger transcriptional repressor) expression as well as epithelial-to-mesenchymal transition (EMT) process. Via wound healing assay and cell invasion assay, experts inquired about the role of Snail in urolithin A-induced EMT inhibition in lung cancer cells. Urolithin A dose-dependently upregulated epithelial marker as well as reduced mesenchymal markers in lung cancer cells. Cell migratory and invasive capacity were reduced by exposure to urolithin A. As inferred based on this study’s findings, the EMT process could be inhibited by urolithin A via controlling mainly Snail expression. Pomegranate’s role in regulation of EMT program in pulmonary malignancy was highlighted by findings.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay